CS187389B2 - Method of producing alkanolamine derivatives - Google Patents

Method of producing alkanolamine derivatives

Info

Publication number
CS187389B2
CS187389B2 CS738727A CS872773A CS187389B2 CS 187389 B2 CS187389 B2 CS 187389B2 CS 738727 A CS738727 A CS 738727A CS 872773 A CS872773 A CS 872773A CS 187389 B2 CS187389 B2 CS 187389B2
Authority
CS
Czechoslovakia
Prior art keywords
alkanolamine derivatives
producing
producing alkanolamine
derivatives
alkanolamine
Prior art date
Application number
CS738727A
Other languages
Czech (cs)
English (en)
Inventor
Leslie H Smith
Original Assignee
Ici Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Ltd filed Critical Ici Ltd
Priority to CS771522A priority Critical patent/CS187396B2/cs
Publication of CS187389B2 publication Critical patent/CS187389B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/20—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/04—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms
    • C07C275/06—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an acyclic and saturated carbon skeleton
    • C07C275/14—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an acyclic and saturated carbon skeleton being further substituted by nitrogen atoms not being part of nitro or nitroso groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CS738727A 1972-12-15 1973-12-17 Method of producing alkanolamine derivatives CS187389B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CS771522A CS187396B2 (en) 1972-12-15 1977-03-07 Process for preparing new derivatives of alkanolamine

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB5797072 1972-12-15
GB4347873A GB1455116A (en) 1972-12-15 1973-09-17 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
CS187389B2 true CS187389B2 (en) 1979-01-31

Family

ID=26265164

Family Applications (1)

Application Number Title Priority Date Filing Date
CS738727A CS187389B2 (en) 1972-12-15 1973-12-17 Method of producing alkanolamine derivatives

Country Status (28)

Country Link
US (2) US3928412A (ja)
JP (1) JPS5919090B2 (ja)
AR (2) AR213930A1 (ja)
AT (3) AT345791B (ja)
BE (1) BE808666A (ja)
CA (1) CA1031362A (ja)
CH (4) CH605668A5 (ja)
CS (1) CS187389B2 (ja)
DD (1) DD113349A5 (ja)
DE (1) DE2362568C2 (ja)
DK (1) DK158466C (ja)
ES (1) ES421538A1 (ja)
FI (1) FI61027C (ja)
FR (1) FR2210407B1 (ja)
GB (1) GB1455116A (ja)
HK (1) HK24480A (ja)
HU (1) HU169087B (ja)
IE (1) IE38602B1 (ja)
IL (1) IL43795A (ja)
IN (1) IN139418B (ja)
KE (1) KE3030A (ja)
LU (1) LU68997A1 (ja)
MY (1) MY8100035A (ja)
NL (1) NL179203C (ja)
NO (1) NO138335C (ja)
SE (1) SE408794B (ja)
SU (2) SU576917A3 (ja)
YU (2) YU40097B (ja)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4038313A (en) * 1970-01-08 1977-07-26 Ciba-Geigy Corporation Cycloalkylureido phenoxy propanolamines
US4167581A (en) * 1972-12-15 1979-09-11 Imperial Chemical Industries Limited Alkanolamine derivatives and pharmaceutical compositions and uses thereof
US4171374A (en) * 1972-12-15 1979-10-16 Imperial Chemical Industries Limited Alkanolamine derivatives
US4117157A (en) * 1973-06-22 1978-09-26 Imperial Chemical Industries Limited Ethanolamine derivatives having β-adrenergic blocking activity
US4034112A (en) * 1973-06-22 1977-07-05 Imperial Chemical Industries Limited Ethanolamine derivatives having β-adrenergic blocking activity
US4041074A (en) * 1973-07-19 1977-08-09 Imperial Chemical Industries Limited 1-Hydroxyaryl-2-amidoalkylaminoethanol derivatives
GB1573359A (en) * 1977-12-20 1980-08-20 Ici Ltd Alkanolamine derivatives
GB1509527A (en) * 1974-06-05 1978-05-04 Ici Ltd 1-(aryl-or heteroaryl)oxy-3-(substituted-amino)propan-2-ol derivatives processes for their manufacture and pharmaceutical compositions containing them
US4041075A (en) * 1973-12-12 1977-08-09 Imperial Chemical Industries Limited Phenoxy-alkanolamine derivatives
AT334385B (de) * 1973-12-20 1976-01-10 Chemie Linz Ag Verfahren zur herstellung von neuen phenoxypropylaminderivaten und deren salzen
US4141987A (en) * 1974-06-05 1979-02-27 Imperial Chemical Industries Limited 1-Aryloxy-3-thenamidoalkylamino-2-propanol derivatives
US4162331A (en) * 1975-06-17 1979-07-24 Nippon Shinyaku Co., Ltd. Substituted N-(carboxymethyl)-3-aminopropan-2-ol derivatives
GB1540463A (en) * 1976-10-07 1979-02-14 Ici Ltd Alkanolamine derivatives
US4172150A (en) * 1977-05-23 1979-10-23 Imperial Chemical Industries Limited Cardiac stimulants
IE47053B1 (en) * 1977-05-23 1983-12-14 Ici Ltd Cardiac stimulants
US4219561A (en) * 1977-09-22 1980-08-26 Imperial Chemical Industries Limited Alkanolamine derivatives
US4239700A (en) * 1978-10-10 1980-12-16 Texaco Development Corp. Isatoic anhydride derivatives and use as chain-extenders
US4281189A (en) * 1979-09-06 1981-07-28 Hoffmann-La Roche Inc. Sulfonamide intermediates for adrenergic blocking agents
US4301300A (en) * 1979-09-06 1981-11-17 Hoffmann-La Roche Inc. Sulfonamide intermediates for adrenergic blocking agents
FR2477537A1 (fr) * 1980-03-07 1981-09-11 Francaise Sucrerie Nouvelles guanidines acylees, urees et urees substituees, leur procede de fabrication et leur application en tant que medicaments
FI76551C (fi) * 1980-11-06 1988-11-10 Sandoz Ag Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 3-aminopropoxifenylderivat.
DE3270905D1 (en) * 1981-12-17 1986-06-05 Haessle Ab Para-substituted 3-phenoxy-1-carbonylaminoalkylamino-propan-2-ols having beta receptor blocking properties
US5238962A (en) * 1983-03-03 1993-08-24 Hoffmann-La Roche Inc. Benzamide derivatives
CH653670A5 (de) * 1983-03-03 1986-01-15 Hoffmann La Roche Benzamid-derivate.
US4593039A (en) * 1984-04-02 1986-06-03 Merck & Co., Inc. 1-aryloxy-3-(substituted aminoalkylamino)-2-propanols
DE3427309A1 (de) * 1984-07-25 1986-01-30 Boehringer Ingelheim KG, 6507 Ingelheim Neue 1-aryloxypropanolamine, verfahren zu ihrer herstellung und ihre verwendung
DE3512627A1 (de) * 1985-04-06 1986-10-09 Boehringer Mannheim Gmbh, 6800 Mannheim Amino-propanol-derivate, verfahren zu deren herstellung, verwendung derselben und diese enthaltende arzneimittel
IE60714B1 (en) * 1985-05-14 1994-08-10 Louis William John "3-aminoproplyloxyphenyl derivatives, their preparation and pharmaceutical compositions containing them"
EP0207036A1 (en) * 1985-06-20 1986-12-30 Aktiebolaget Hässle New para-substituted 3-phenoxy-1-piperidinecarbonylaminoalkylamino-propanol-2-s having beta receptor blocking properties.
GB8607313D0 (en) * 1986-03-25 1986-04-30 Ici Plc Pharmaceutical compositions
GB8607312D0 (en) * 1986-03-25 1986-04-30 Ici Plc Therapeutic agents
NZ226934A (en) * 1987-11-13 1991-01-29 Glaxo Group Ltd Phenethanolamine derivatives and pharmaceutical compositions
JP2004137284A (ja) * 1997-06-17 2004-05-13 Kaken Pharmaceut Co Ltd ２−スルファモイル安息香酸誘導体
GB0417802D0 (en) * 2004-08-10 2004-09-15 Novartis Ag Organic compounds
CN106977426A (zh) * 2017-05-27 2017-07-25 哈尔滨师范大学 一种腰果酚苯基脲及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3459782A (en) * 1963-08-26 1969-08-05 Boehringer Sohn Ingelheim 1-substituted phenoxy-2-hydroxy-3-isopropylamino-propanes
GB1199037A (en) * 1967-09-27 1970-07-15 Ici Ltd Alkanolamine Derivatives
GB1285038A (en) * 1969-02-21 1972-08-09 Ici Ltd Alkanolamine derivatives
BE754604A (fr) * 1969-08-08 1971-02-08 Boehringer Sohn Ingelheim Le 1-(2-nitrilophenoxy)-2-hydroxy-3-ethyl-aminopropane et ses sels

Also Published As

Publication number Publication date
YU280680A (en) 1983-09-30
IL43795A (en) 1978-03-10
YU42539B (en) 1988-10-31
IL43795A0 (en) 1974-03-14
IN139418B (ja) 1976-06-19
NL179203C (nl) 1986-08-01
DE2362568A1 (de) 1974-06-20
AT344144B (de) 1978-07-10
CH605668A5 (ja) 1978-10-13
DK158466C (da) 1990-10-15
CH605667A5 (ja) 1978-10-13
NO138335C (no) 1978-08-16
AT351557B (de) 1979-08-10
DD113349A5 (ja) 1975-06-05
NL179203B (nl) 1986-03-03
ATA566077A (de) 1979-01-15
JPS5919090B2 (ja) 1984-05-02
SU576917A3 (ru) 1977-10-15
KE3030A (en) 1980-03-14
LU68997A1 (ja) 1974-02-22
FR2210407A1 (ja) 1974-07-12
YU324673A (en) 1982-02-28
NL7317096A (ja) 1974-06-18
BE808666A (fr) 1974-06-14
SU695555A3 (ru) 1979-10-30
FI61027C (fi) 1982-05-10
MY8100035A (en) 1981-12-31
HK24480A (en) 1980-05-16
AR214288A1 (es) 1979-05-31
CH611876A5 (en) 1979-06-29
AT345791B (de) 1978-10-10
ES421538A1 (es) 1976-07-16
AR213930A1 (es) 1979-04-11
DK158466B (da) 1990-05-21
FI61027B (fi) 1982-01-29
IE38602B1 (en) 1978-04-26
CH605666A5 (ja) 1978-10-13
JPS4994638A (ja) 1974-09-09
ATA266376A (de) 1977-11-15
FR2210407B1 (ja) 1978-01-13
US4010189A (en) 1977-03-01
DE2362568C2 (de) 1983-11-03
CA1031362A (en) 1978-05-16
SE408794B (sv) 1979-07-09
YU40097B (en) 1985-08-31
IE38602L (en) 1974-06-15
US3928412A (en) 1975-12-23
NO138335B (no) 1978-05-08
GB1455116A (en) 1976-11-10
HU169087B (ja) 1976-09-28

Similar Documents

Publication Publication Date Title
CS187389B2 (en) Method of producing alkanolamine derivatives
CS187390B2 (en) Method of producing novel derivatives of benzimidazol-2-carbamic acid
BG32717A3 (en) Method for obtaining of n- organo- n- phosphonomethylglicine- n- oxides
CS182793B2 (en) Method for production of substituted ce-pentanorprostaglandins
CS168033B2 (en) Method of urea production
CS183686B2 (en) Method of producing 1-hydroxy-2-pyridones
CS183721B2 (en) Method of production of alfa-aminoacylcephalosporines
PH9508A (en) Process for preparing derivatives of 1-phenoxy-3-amino propane-2-01
CH614925A5 (en) Process for the preparation of alkanolamine derivatives
CS182234B2 (en) Method of producing n-benzhydryl-n-p-hydroxy-benzylpiperazine
CS192502B2 (en) Method of preparing derivatives of 3-carbamoyl-oxymethyl-cephalosporin
CS191212B2 (en) Method of producing lysergamides
CS192504B2 (en) Method of producing cyano-methyl-thioacetyl-cephalosporins
HU172069B (hu) Sposob poluchenija proizvodnykh 1-skobka-3-dvojjnozamehhennykh-fosfono-tioureido-skobka zakryta-2-skobka-3-zamehhennykh-ureido- ili -tioureido-skobka zakryta-benzolov
BG24661A3 (en) Method of preparing d-1-11-deoxoprostaglandine-e
CS181234B2 (en) Method of producing benzodioxol derivatives
CS188175B2 (en) Method of producing 15-substituted omega-nor-prostaglandins
CS183726B2 (en) Method for producing derivatives of triazole
HU167876B (en) Process for producing 9-10-secoestrane derivatives
CS181238B2 (en) Method of preparing 2-benzoyl-3-aminopyridines
CS187377B2 (en) Method of producing novel cyclohexone derivatives
CS193022B2 (en) Method of producing derivatives of phosphonourea or phosphonothiourea
HU173381B (hu) Sposob poluchenija proizvodnykh karboksi-ciklopropanov
CS181249B2 (en) Method of producing alkanolamine derivatives
CS193019B2 (en) Method of producing 15alpha-methylene-4-estrene-17beta-ols